Evidence map›Paper›PMID 40583043›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2025

Menopause, Menstrual Cycle, and Skin Barrier Function.

Đurđa Cvjetković Nikoletić, David Ivanov, Olivera Levakov, Jelena Bulajić, Sonja Lukač, Vedrana Karan Rakić, Milana Ivkov-Simić

Erratum issuedAbstract read
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Đurđa Cvjetković NikoletićDepartment of Physiology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.ORCID https://orcid.org/0000-0003-3224-2648
David IvanovDepartment of Physiology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Olivera LevakovClinic of Dermatovenereology Diseases, Clinical Center of Vojvodina, Novi Sad, Serbia.ORCID https://orcid.org/0000-0001-7624-1220
Jelena BulajićClinic of Dermatovenereology Diseases, Clinical Center of Vojvodina, Novi Sad, Serbia.
Sonja LukačClinical Center of Vojvodina, Center for Radiology, Novi Sad, Serbia.
Vedrana Karan RakićDepartment of Physiology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Milana Ivkov-SimićClinic of Dermatovenereology Diseases, Clinical Center of Vojvodina, Novi Sad, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are a limited number of studies describing the impact of the menstrual cycle and postmenopause on the skin barrier function, and existing research data are conflicting. The aim of our research was to investigate the impact of the menstrual cycle and postmenopause on the epidermal barrier function and its main biophysical parameters-transepidermal water loss (TEWL) and skin hydration (SH). MATERIALS AND

methodsEighty-one female participants were included in the study, aged 18-65 years, of which 36 in the reproductive period (average age 27.06 ± 5.60 years) and 45 in postmenopause (average age 56.56 ± 4.37 years). TEWL and SH were measured during the ovulatory and mid-luteal phases in participants in the reproductive period, and on two occasions, 7 days apart, in posmenopausal participants.

resultsThe mean TEWL value was significantly higher in the mid-luteal phase (TEWL 2; 9.92 ± 1.37) compared to the ovulatory phase (TEWL 1; 8.87 ± 1.59). However, no significant difference in TEWL was observed between the two groups of participants. The mean SH value was significantly higher in the ovulatory phase (SH 1; 40.55 ± 7.80) compared to the mid-luteal phase (SH 2; 36.27 ± 7.42). Moreover, SH in the ovulatory phase was significantly higher in comparison to the postmenopausal group (40.55:36.27; p = 0.009).

conclusionOur study indicates a more functional epidermal barrier during the ovulatory phase, as evidenced by higher TEWL values and lower SH values compared to the mid-luteal phase. However, the differences between the two participant groups remain intriguing, as no significant difference in TEWL was observed between them, despite significantly higher SH values in the ovulatory phase compared to the postmenopausal group.

Indexed as

EpidermisMenopauseMenstrual CycleSkin Physiological PhenomenaWater Loss, InsensibleAdolescentAdultAgedFemaleHumansMiddle AgedPostmenopauseSkinYoung Adultmenopausemenstrual cycleskin barrierskin hydrationtransepidermal water loss

Identifiers

PMID40583043
PMCPMC12206585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.